General Hospital
FDA Headquarters
Regulatory & QualityMedline Reaps FDA Ire in Class I Endotracheal Tube RecallMedline Reaps FDA Ire in Class I Endotracheal Tube Recall
The company has been under FDA spotlight since its link to the China plastic syringe manufacturing safety communication was announced earlier this year.
Sign up for the QMED & MD+DI Daily newsletter.